Pishvaian MJ, Lee MS, Ryoo B, et al. Updated safety and clinical activity results from a Phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC). ESMO 2018, abstract LBA26.
Perianale Crohn en de ontwikkeling van colorectaal en anuscarcinoom
jul 2023 | IBD, Maag-darm-leveroncologie